In multiple animal and in-vitro studies, both peptides have demonstrated high tolerability and absence of systemic toxicity
Notably, intravenous glutathione has a short plasma half-life, with most of the administered dose being cleared from circulation within minutes
Bridge, Glutamate cysteine ligase and the age-related decline in cellular glutathione: The therapeutic potential of -glutamylcysteine
It also boosts your immune system by reducing oxidative stress and protecting cells from free radicals, which are unstable molecules that may damage the growth and survival of cells in the body (Pizzorno, 2014)
In addition, confirming the efficacy of GSH treatment, a reduction in malondialdehyde, a marker of hepatic cell damage, was detected